
EMA NAM Data Pilot: Eligibility and Evidence Readiness
A 2026 guide to EMA NAM pilot eligibility, four regulatory applicability areas, pathway selection, Module 2.4 package design, and evidence-readiness scoring.
IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

A 2026 guide to EMA NAM pilot eligibility, four regulatory applicability areas, pathway selection, Module 2.4 package design, and evidence-readiness scoring.

Learn the critical differences between preclinical and clinical research in drug development, from lab-based toxicology (GLP) to human clinical trials (GCP). Updated with FDA Modernization Act 3.0, NAMs guidance (2026), AI drug discovery trends, and current attrition data.
© 2026 IntuitionLabs. All rights reserved.